Dr. Stefan Verheye
Dr. Stefan Verheye, MD, PhD, has been a senior interventional cardiologist at the Antwerp Cardiovascular Center, Antwerp Belgium since 2000. He is a member of the European Association of Percutaneous Cardiovascular Interventions, a member of the Belgian Working Group on Interventional Cardiology, and has been appointed as Clinical Professor Interventional Cardiology at the University of Brussels. He serves as a member of Scientific Advisory Board of several medical device manufacturers. Dr. Verheye is the author of over 150 peer-reviewed journals (www.pubmed.com), ten book chapters, over 400 abstracts, and has led (as global principal investigator) and participated in numerous clinical (Phase I and II) and pre-clinical research studies in the field of innovative interventional cardiology (coronary artery disease, structural heart disease, heart failure). He has presented at numerous major conferences such as TCT (Transcatheter Cardiovascular Therapeutics), EuroPCR (European Percutaneous Course on Revascularization), AsiaPCR, AHA (American Heart Association), ACC (American College of Cardiology) and ESC (European Society of Cardiology) and has directed and transmitted several coronary and structural live cases to TCT, EuroPCR and ESC. He served as the medical director for V-Wave, Israel, a medical device company, developing and manufacturing inter-atrial shunt for heart failure. His entrepreneurial interests led to the co-foundation of Hilbert Paradox, NV, a start-up company encompassing a unique way of capturing and correlating digital health data, applying data- and knowledge engineering, which was later on acquired by a large CRO. He co-founded ainthoven, NV, a start-up company dedicated to on-line cardiac signal analytics by exploring the hyperspace of learning algorithms, and recently co-founded Amynas, BV a Belgian based, incorporated technology platform company specializing in nanofiber electrospinning providing anti-infective and anti-inflammatory protection for implanted devices, including CIEDs, neuro-stimulatory and orthopedic devices.
Stefan Verheye graduated from the School of Medicine at the University of Leuven in Belgium and was a resident internal medicine and cardiology both at the University of Aachen, Germany and OLV-Hospital, Aalst, Belgium. After a 2-year fellowship interventional cardiology in Aalst, Belgium, he completed a 2-year period as a research associate and visiting interventional cardiologist at the Andreas Gruentzig Cardiovascular Center at Emory University School of Medicine in Atlanta, Georgia, and served as an affiliate scientist, Division of Molecular Medicine for Yerkes Regional Primate Research Center of Emory University. He earned his PhD at the Department of Pharmaceutical Sciences of the University of Antwerp.